Medicines taken by older Australians after transient ischaemic attack or ischaemic stroke: a retrospective database study

Janet Sluggett, Gillian Caughey, Michael B. Ward, Andrew L. Gilbert

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Background Guidelines recommend patients diagnosed with transient ischaemic attack (TIA) or ischaemic stroke receive antihypertensive, antithrombotic and lipid lowering medicines. Reassessment of the need for medicines associated with an increased risk of stroke is also recommended. Objective To determine changes in the use of medicines recommended for secondary stroke prevention, medicines commonly used for treating stroke-related complications and medicines not recommended for use after ischaemic stroke, and to determine patient characteristics associated with use of all three stroke prevention medicines after TIA or ischaemic stroke. Setting Administrative health claims data from the Australian Government Department of Veterans’ Affairs. Method This retrospective study included patients with a first-ever hospitalisation for TIA or ischaemic stroke in 2009 and alive at 4 months after discharge. Changes to medicines dispensed in the 4 months before and after hospitalisation were compared using McNemar’s test. Log binomial regression analysis was used to determine patient characteristics associated with use of all three secondary stroke prevention medicines after hospitalisation for TIA or ischaemic stroke. Main outcome measure Prevalence of medicine use after hospitalisation. Results 1541 patients (853 TIA, 688 ischaemic stroke) were included, with a median age of 85 years. High use of antihypertensive (82 % TIA, 86 % ischaemic stroke) and antithrombotic (84 % TIA, 90 % ischaemic stroke) medicines was observed postdischarge, with 58 % of TIA and 73 % of ischaemic stroke patients receiving lipid lowering therapy. Half of the population (47 % TIA, 61 % ischaemic stroke) were dispensed all three classes of medicines recommended for secondary stroke prevention after discharge. Ischaemic stroke patients, younger patients, patients with more comorbid conditions and those discharged home were more likely to receive all three recommended medicine classes. Antibiotics (45 % TIA, 46 % ischaemic stroke), paracetamol (44 % TIA, 47 % ischaemic stroke), antidepressants (26 % TIA, 31 % ischaemic stroke) and laxatives (24 % TIA, 32 % ischaemic stroke) were commonly used after discharge. Increased use of sedatives and reduced use of non-steroidal anti-inflammatories was also observed after discharge. Conclusion Changes to pharmacotherapy after TIA or ischaemic stroke were consistent with treatment for stroke risk factors and common stroke-related complications. Use of secondary stroke prevention medicines may be further improved among TIA patients.

LanguageEnglish
Pages782-789
Number of pages8
JournalInternational Journal of Clinical Pharmacy
Volume37
Issue number5
DOIs
Publication statusPublished - 1 Oct 2015
Externally publishedYes

Keywords

  • Australia
  • Drug utilisation
  • Older people
  • Stroke
  • Transient ischaemic attack

ASJC Scopus subject areas

  • Pharmacy
  • Toxicology
  • Pharmacology
  • Pharmaceutical Science
  • Pharmacology (medical)

Cite this